Screener
IDEAYA Biosciences, Inc. IDYA Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Collaboration revenue | $6,560 | — |
| Total revenue | 6,560 | — |
| Operating expenses | ||
| Research and development | 95,726 | 70,886 |
| General and administrative | 19,378 | 13,503 |
| Total operating expenses | 115,104 | 84,389 |
| Loss from operations | (108,544) | (84,389) |
| Other income |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s total revenue?
- IDEAYA Biosciences, Inc. (IDYA) reported total revenue of $6.56M in Q1 2026.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s total revenue?
- Over 3 years (2021 to 2024), IDEAYA Biosciences, Inc.'s total revenue has grown at a -37.0% compound annual growth rate (CAGR), from $27.94M to $7M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about IDEAYA Biosciences, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude